🇯🇵 Drug: Apixaban sprinkle capsules in Japan

Drug: Apixaban sprinkle capsules (Drug: Apixaban sprinkle capsules) regulatory status in Japan.

Marketing authorisation

Drug: Apixaban sprinkle capsules in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Drug: Apixaban sprinkle capsules approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for Drug: Apixaban sprinkle capsules in Japan?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.